Sexual functioning in patients with chronic hepatitis C: a systematic review

Katerina Karaivazoglou1, Evangelia-Eirini Tsermpini, Konstantinos Assimakopoulos

  • 1Departments of aPsychiatry bGastroenterology, School of Medicine cPharmacy, Laboratory of Molecular Biology and Immunology, School of Health Science, University of Patras, Rion, Patras, Greece.

Insights

Chronic hepatitis C virus (HCV) infection significantly impacts sexual health, causing dysfunction in desire and satisfaction. This review synthesizes data on HCV-associated sexual impairment, identifying key patterns and research gaps.

Area of Science:

  • Hepatology
  • Sexual Medicine
  • Public Health

Background:

  • Chronic hepatitis C virus (HCV) infection is a systemic illness affecting overall well-being, including sexual health.
  • HCV-related sexual health disturbances are often overlooked by clinicians despite significant patient impact.

Purpose of the Study:

  • To conduct a systematic literature review on sexual functioning in chronic hepatitis C virus (HCV) patients.
  • To identify high-quality studies reporting scientifically sound data on HCV-associated sexual dysfunction.

Main Methods:

  • Systematic literature search of PubMed, ScienceDirect, and Google Scholar using PRISMA guidelines.
  • Inclusion of 25 articles reporting data from over 5300 chronic HCV patients.

Main Results:

  • Sexual dysfunction, particularly in desire and satisfaction, affects 19-88% of HCV patients.
  • Three patterns identified: precirrhotic impairment, cirrhosis-related decline, and interferon-associated difficulties.
  • Prevalence, characteristics, and determinants of HCV-associated sexual dysfunction were analyzed.

Conclusions:

  • HCV significantly impacts sexual functioning, with distinct patterns of impairment.
  • Further research is needed to address scientific controversies and information gaps in HCV-associated sexual dysfunction.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
301
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
225
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
273
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.3K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K